Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: Two case reports

Dermatology

Volumn 221, Issue 3, 2010, Pages 201-205

  Boussemart, L ^a   Jacobelli, S ^a   Batteux, F ^a   Goulvestre, C ^a   Grange, P ^a   Carlotti, A ^a   Morini, J P ^a   Gorin, I ^a   Ziza, J M ^b   Avril, M F ^a   Dupin, N ^a,c  

^a Hôpital Cochin   (India)

^b GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

^c Institut Cochin   (France)

Author keywords

Anti TNF therapy; Bullous pemphigoid; Pemphigus foliaceus

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ALLOCHRYSINE; AZATHIOPRINE; BASEMENT MEMBRANE ANTIBODY; BISOPROLOL; CALCIUM CARBONATE; CLOBETASOL PROPIONATE; COLECALCIFEROL; COLLAGEN TYPE 17; CORTICOSTEROID; DAPSONE; DESMOGLEIN 1; ETANERCEPT; FLUINDIONE; HYDROCHLOROTHIAZIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLIXIMAB; LEFLUNOMIDE; LORATADINE; METHOTREXATE; OMEPRAZOLE; PARACETAMOL; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE SKIN DISEASE; BLISTER; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA DISEASE; GINGIVAL BIOPSY; HUMAN; IMMUNOFLUORESCENCE; MALE; MOUTH MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; NAUSEA; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; PROTEINURIA; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN INFLAMMATION; SOMNOLENCE;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PEMPHIGUS; TUMOR NECROSIS FACTORS;

EID: 78049473647     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318008     Document Type: Article

References (30)

1. Patrício P, Ferreira C, Gomes Mm, Filipe P: Autoimmune Bullous Dermatoses: A Review. Ann N Y Acad Sci 2009; 1173: 203-210.
2. Brenner S, Wolf R, Ruocco V: Drug-Induced Pemphigus. I. A Survey. Clin Dermatol 1993; 11: 501-505. (Pubitemid 24024933)
3. Lee Jj, Downham Tf 2Nd: Furosemide-Induced Bullous Pemphigoid: Case Report And Review Of Literature. J Drugs Dermatol 2006; 5: 562-564.
4. Haraoui B: Differentiating The Efficacy Of The Tumor Necrosis Factor Inhibitors. Semin Arthritis Rheum 2005; 34: 7-11. (Pubitemid 40502154)
5. Nurmohamed Mt, Dijkmans Ba: Efficacy, Tolerability And Cost Effectiveness Of Diseasemodifying Antirheumatic Drugs And Biologic Agents In Rheumatoid Arthritis. Drugs 2005; 65: 661-694.
6. Ramos-Casals M, Brito-Zerón P, Soto Mj, Cuadrado Mj, Khamashta Ma: Autoimmune Diseases Induced By Tnf-Targeted Therapies. Best Pract Res Clin Rheumatol 2008; 22: 847-861.
7. Batteux F, Franck N, Jaffray P, Raulo M, Prost C, Leibowitch M, Escande Jp, Weill B: An Extract From Cultured Human Keratinocytes That Contains The Major Autoantigens Related To Autoimmune Bullous Skin Diseases. J Clin Immunol 1997; 17: 228-233. (Pubitemid 27261696)
8. Green H, Rheinwald Jg, Sun Tt: Properties Of An Epithelial Cell Type In Culture: The Epidermal Keratinocyte And Its Dependence On Products Of The Fibroblast. Prog Clin Biol Res 1977; 17: 493-500.
9. Lazarova Z, Salato Vk, Lanschuetzer Cm, Janson M, Fairley Ja, Yancey Kb: Igg Antilaminin- 332 Autoantibodies Are Present In A Subset Of Patients With Mucous Membrane, But Not Bullous, Pemphigoid. J Am Acad Dermatol 2008; 58: 951-958.
10. Joly P, Roujeau Jc, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study Group. A Comparison Of Oral And Topical Corticosteroids In Patients With Bullous Pemphigoid. N Engl J Med 2002; 346: 321-327.
11. Joly P, Roujeau Jc, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume Jc, Doutre Ms, Richard Ma, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot Mf, Esteve E, Bernard P: A Comparison Of Two Regimens Of Topical Corticosteroids In The Treatment Of Patients With Bullous Pemphigoid: A Multicenter Randomized Study. J Invest Dermatol 2009; 129: 1681-1687.
12. Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P: Treatment Of Severe Pemphigus With Rituximab: Report Of 12 Cases And A Review Of The Literature. Arch Dermatol 2007; 143: 1033-1038. (Pubitemid 47296080)
13. D'Auria L, Cordiali Fei P, Ameglio F: Cytokines And Bullous Pemphigoid. Eur Cytokine Netw 1999; 10: 123-134. (Pubitemid 29332767)
14. Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A, Giacalone B: Cytokine Pattern In Blister Fluid And Serum Of Patients With Bullous Pemphigoid: Relationships With Disease Intensity. Br J Dermatol 1998; 138: 611-614. (Pubitemid 28212243)
15. Wolf R, Tamir A, Brenner S: Drug-Induced Versus Drug-Triggered Pemphigus. Dermatologica 1991; 182: 207-210.
16. Wolf R, Brenner S: An Active Amide Group In The Molecule Of Drugs That Induce Pemphigus: A Casual Or Causal Relationship? Dermatology 1994; 189: 1-4. (Pubitemid 24126362)
17. Baroni A, Buommino E, Paoletti I, Orlando M, Ruocco E, Ruocco V: Pemphigus Serum And Captopril Induce Heat Shock Protein 70 And Inducible Nitric Oxide Synthase Overexpression, Triggering Apoptosis In Human Keratinocytes. Br J Dermatol 2004; 150: 1070-1080. (Pubitemid 38932275)
18. Bonecchi R, Bianchi G, Bordignon Pp, Igaglia Al: Differential Expression Of Chemokine Receptors And Chemotactic Responsiveness Of Type 1 T Helper Cells (Th1S) And Th2S. J Exp Med 1998; 187: 129-134. (Pubitemid 28044828)
19. Frezzolini A, Teofoli P, Cianchini G, Barduagni S, Ruffelli M, Ferranti G, Puddu P, Pita Od: Increased Expression Of Eotaxin And Its Specific Receptor Ccr3 In Bullous Pemphigoid. Eur J Dermatol 2002; 12: 27-31. (Pubitemid 34131135)
20. Gounni Abdelilah S, Wellemans V, Agouli M, Guenounou M, Hamid Q, Beck La, Lamkhioued B: Increased Expression Of Th2-Associated Chemokines In Bullous Pemphigoid Disease: Role Of Eosinophils In The Production And Release Of These Chemokines. Clin Immunol 2006; 120: 220-231. (Pubitemid 44080677)
21. Veldman C, Höhne A, Dieckmann D, Schuler G, Hertl M: Type I Regulatory T Cells Specific For Desmoglein 3 Are More Frequently Detected In Healthy Individuals Than In Patients With Pemphigus Vulgaris. J Immunol 2004; 172: 6468-6475. (Pubitemid 38621257)
22. Kennedy Js, Devillez Rl, Henning Js: Recalcitrant Cicatricial Pemphigoid Treated With The Anti-Tnf-Alpha Agent Etanercept. J Drugs Dermatol 2010; 9: 68-70.
23. Jacobi A, Antoni C, Manger B, Schuler G, Hertl M: Infliximab In The Treatment Of Moderate To Severe Atopic Dermatitis. J Am Acad Dermatol 2005; 52: 522-526.
24. Liu Ly, Bates Me, Jarjour Nn, Busse Ww, Bertics Pj, Kelly Ea: Generation Of Th1 And Th2 Chemokines By Human Eosinophils: Evidence For A Critical Role Of Tnf-Alpha. J Immunol 2007; 179: 4840-4848.
25. Cañete Jd, Martínez Se, Farrés J, Sanmartí R, Blay M, Gómez A, Salvador G, Muñoz- Gómez J: Differential Th1/Th2 Cytokine Patterns In Chronic Arthritis: Interferon Gamma Is Highly Expressed In Synovium Of Rheumatoid Arthritis Compared With Seronegative Spondyloarthropathies. Ann Rheum Dis 2000; 59: 263-268. (Pubitemid 30305567)
26. Zhu K, Ye J, Wu M, Cheng H: Expression Of Th1 And Th2 Cytokine-Associated Transcription Factors, T-Bet And Gata-3, In Peripheral Blood Mononuclear Cells And Skin Lesions Of Patients With Psoriasis Vulgaris. Arch Dermatol Res 2010, E-Pub Ahead Of Print.
27. Ko Jm, Gottlieb Ab, Kerbleski Jf: Induction And Exacerbation Of Psoriasis With Tnfblockade Therapy: A Review And Analysis Of 127 Cases. J Dermatolog Treat 2009; 20: 100-108.
28. Weaver Ct, Hatton Rd, Mangan Pr, Harrington Le: Il-17 Family Cytokines And The Expanding Diversity Of Effector T Cell Lineages. Annu Rev Immunol 2007; 25: 821-852.
29. Zaba Lc, Suárez-Fariñas M, Fuentes-Duculan J, Nograles Ke, Guttman-Yassky E, Cardinale I, Lowes Ma, Krueger Jg: Effective Treatment Of Psoriasis With Etanercept Is Linked To Suppression Of Il-17 Signaling, Not Immediate Response Tnf Genes. J Allergy Clin Immunol 2009; 124: 1022-10.E1-395.
30. Shi G, Ramaswamy M, Vistica Bp, Cox Ca, Tan C, Wawrousek Ef, Siegel Rm, Gery I: Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation And Are Highly Resistant To Restimulation-Induced Cell Death. J Immunol 2009; 183: 7547-7556.